Milestone Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $559 | $238 | $1,546 | $0 |
Gross Profit | 527 | 168 | 1,546 | -24 |
EBITDA | -23,832 | -21,984 | -16,390 | -11,003 |
EBIT | -23,889 | -22,040 | -16,424 | -11,027 |
Net Income | -28,614 | -26,066 | -17,409 | -11,922 |
Net Change In Cash | 559 | 238 | 1,546 | 0 |
Free Cash Flow | -22,559 | -16,053 | -12,786 | -9,817 |
Cash | 169,728 | 71,317 | 73,046 | 46,685 |
Basic Shares | 138,691 | 130,286 | 83,882 | 85,169 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,546 | $0 | $1,000 | $5,000 |
Gross Profit | 1,432 | -646 | 1,000 | 5,000 |
EBITDA | -59,451 | -37,833 | -57,039 | -59,553 |
EBIT | -59,565 | -37,938 | -57,131 | -59,642 |
Net Income | -63,058 | -41,519 | -59,685 | -57,134 |
Net Change In Cash | 1,546 | 0 | 1,000 | 5,000 |
Free Cash Flow | -49,343 | -28,881 | -46,536 | -52,741 |
Cash | 73,046 | 25,314 | 13,760 | 7,636 |
Basic Shares | 83,882 | 62,210 | 42,955 | 42,450 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.21 |
2026-03-31 | -$0.20 |
2025-12-31 | -$0.15 |
2025-09-30 | -$0.12 |